Unusual Options Activity: Fastenal (FAST)

Hardware and construction equipment company may be in for a big drop. A large bet has been made that shares of Fastenal (FAST) will decline 25 percent by January 2021. On Monday, over 2,000 contracts of the January 2021 $25 put options contracts had been traded, against an open interest of 142, representing a 14-fold surge in volume. This bet, with shares currently at $32.50, would need to see shares decline at least 25 percent before paying off. With Fastenal’s business in construction ...
Read More
|

Insider Activity: NGM Biopharmaceuticals (NGM)

Another biopharma firm sees insider buying here. Insiders in the pharma and biotech space continue to be bullish near current prices at many companies. The latest insider buys in the space occurred at NGM Biopharmaceuticals (NGM). Column Group LP, already a major owner with more than a 10 percent stake, bought another 34,000 shares late last week. These buys were shown as going to director Peter Svennilson. Director David Goeddel also picked up shares late last week as well. It’s always refreshing to ...
Read More
|

Insider Activity: Associated Capital Group (AC)

Billionaire owner adds to beaten-down research firm. Billionaire investor Mario Gabelli bought 3,544 shares of Associated Capital Group (AC) on June 20th. This doubles his personal share stake, but Gabelli is also Executive Chairman and owns more of the company through his Gabelli funds. The New-York based company was founded in 1976 by Gabelli as an institutional research firm based on bottom-up research and generating market-beating returns. Shares of the firm have traded between $32 and $46 in the past year, and currently ...
Read More
|

Unusual Options Activity: Barrick Gold (GOLD)

Traders bet on a gold decline. After gold hit a 5-year high, one trader is betting on a pullback. On Friday, a bearish bet was made on Barrick Gold (GOLD). On Friday, over 7,100 contracts of the November $14 put options contracts had been traded, against an open interest of 155, representing a 46-fold surge in volume. This bet, with shares currently at $15.40, would need to see shares decline at least 9 percent between now and November to move in-the-money. Gold can ...
Read More
|

Unusual Options Activity: Snapchat (SNAP)

Traders bet on rise in social media company. A bullish bet is being made that shares of Snapchat (SNAP) will continue to rally in the next few weeks. On Thursday, over 11,700 contracts of the July 12th $15.50 call options contracts had been traded, against an open interest of 106, representing a 110-fold surge in volume. This bet, with shares currently at $14.70, implies that shares will rally by at least 5.4 percent in the next month. Shares of the social media giant ...
Read More
|

Insider Activity: Scientific Games Corp (SGMS)

Shares of gaming technology company are down over 60 percent from 52-week highs. Billionaire investor Ron Perelman bought 120,000 shares of Scientific Games Corp (SGMS) on Wednesday, June 19th. The total cost came in at over $2.34 million. Perelman is already a director at the company, and also a 10 percent owner as well. The Las Vegas-based company develops technology related to the gaming industry, including physical gaming machines, video lottery systems, and related hardware and software. With data showing a slowdown in ...
Read More
|

Unusual Options Activity: Qualcomm (QCOM)

Traders bet on 35 percent jump in shares by midsummer. A large bet is being made that shares of Qualcomm (QCOM) will rally to $95 per share by the middle of August. On Wednesday, over 4,600 of the August 16th call options contracts had been traded, against an open interest of 278. This bet, with shares currently at $71, implies that shares will move higher by around 33 percent in the next two months. The unusual move in options contracts started ahead of ...
Read More
|

Insider Activity: Provention Bio (PRVB)

Insiders buy after shares already triple. Multiple insiders have been buying shares at Provention Bio (PRVB), a clinical stage biopharmaceutical company with a focus on preventing immune-mediated diseases. On June 18th, President and CEO Ashleigh Palmer bought 4,000 shares, paying over $43,000. And director Anthony Digiandomenico picked up 10,000 shares, paying over $118,000. This buy comes at an interesting time. The company had previously announced a public stock offering, but terminated the plan, while citing market conditions. The company also recently tripled after ...
Read More
|